PT  - JOURNAL ARTICLE
ED - BMJ Publishing Group Ltd
TI  - ▾Lisinopril - another ACE inhibitor
AID  - 10.1136/dtb.27.8.31
DP  - 1989 Apr 17
TA  - Drug and Therapeutics Bulletin
PG  - 31--32
VI  - 27
IP  - 8
4099  - http://dtb.bmj.com/content/27/8/31.short
4100  - http://dtb.bmj.com/content/27/8/31.full
SO  - Drug Ther Bull1989 Apr 17; 27
AB  - Lisinopril (Carace - MSD, Zestril - ICI) has joined captopril and enalapril1 as the third inhibitor of angiotensin-converting enzyme (ACE), for use in hypertension and heart failure. Advantages claimed for lisinopril are that it is not a pro-drug, its once daily dosage and its ability “to retain that zest for life” during antihypertensive therapy.